Effects of gadolinium-based contrast agents on the cardiac diffusion-weighted images of phantoms and patients
摘要
To investigate the effects of gadolinium-based contrast agent (GBCA) on cardiac diffusion-weighted imaging (cDWI) and cDWI feasibility during the interval between GBCA administration and late gadolinium enhancement (LGE) imaging to streamline workflow.
Materials and methodsPhantoms containing varying GBCA concentration (0–1.0 mM/L) were scanned with stimulated echo acquisition mode-based cDWI (STEAM-cDWI) with various heart rates (HRs) (30–200 beats/min) and second-order motion-compensated spin-echo-based cDWI (M2SE-cDWI) with various echo times (TEs) (75–500 ms). For patient study, 9 patients underwent STEAM-cDWI and 13 underwent M2SE-cDWI before and after GBCA administration. Contrast ratio (CR) and contrast-to-noise ratio (CNR) between the left ventricular myocardium and cavity, and ADC values were assessed.
ResultsIn phantoms, higher GBCA concentration, lower HR, and prolonged TE reduced SI. In STEAM-cDWI, CR and CNR significantly reduced after GBCA administration (CR of b = 400, 2.29 [1.80–5.46] vs. 1.15 [0.78–1.29], p = 0.0004; CNR of b = 400, 7.58 [4.82–11.1] vs. 0.57 [− 1.34 to 1.35], p = 0.0006; respectively); ADC values remained unchanged. In M2SE-cDWI, ADC values significantly decreased after GBCA administration (1.62 [1.15–1.97] vs. 1.26 [1.12– 1.51], × 10–3 mm2/s respectively, p = 0.004); only CR at b = 400 decreased significantly.
DiscussioncDWI is not recommended during the interval between GBCA administration and LGE imaging.